×
Back to Agenda
ON DEMAND - Updates of Drug Evaluation and Inspection in China
Session Chair(s)
Ling Su, PHD
Research Fellow, Yeehong Business School, China
This forum will include discussions and updates from CCDIE and NMPA leadership on many important topics including the implementation of the revision of drug law and updated regulations, ICH implementation, and advanced therapy.
Learning Objective : Discuss updates from CCDIE and NMPA leadership.
Speaker(s)
New Progress of New Drug Evaluation
Project Manager, Center for Drug Evaluation (CDE), National Medical Products Administration (NMPA), China
Pre-Approval Inspection in China: Its Evolution and Key Points of Evaluation Principles
Deputy Division Director, Div 4, Center for Food and Drug Inspection (CFDI), China
Key Points and Evaluation Principles of Pre-Approval Inspection in China
Deputy Division Director, Inspection Division 4, Center for Food and Drug Inspection (CFDI), China
Have an account?